InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector
09. Juni 2022 07:30 ET
|
InMed Pharmaceuticals Inc.
Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoidBolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBTTHCV has been researched for a variety of potential...